NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.;NOVARTIS AG
发明人:
申请号：
IL21808412
公开号：
IL218084A
申请日:
2012.02.13
申请国别(地区):
IL
年份:
2016
代理人:
摘要：
The invention provides a novel class of compounds of formula 1, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
